{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T11:59:45Z","timestamp":1782215985508,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurogenetics"],"DOI":"10.1007\/s10048-025-00853-4","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T06:47:18Z","timestamp":1760683638000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Gaucher syndrome: report of six cases and review of genetic mutations among Iranian patients"],"prefix":"10.1007","volume":"26","author":[{"given":"Mohammad","family":"Miryounesi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohadeseh","family":"Fathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheyda","family":"Khalilian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faezeh","family":"Sherafat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soudeh","family":"Ghafouri-Fard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadab","family":"Salehpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"issue":"11\/01\/17","key":"853_CR1","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.ejim.2006.07.005","volume":"2006","author":"A Mehta","year":"2006","unstructured":"Mehta A (2006) Epidemiology and natural history of gaucher\u2019s disease. Eur J Intern Med 2006(11\/01\/17):S2\u2013S5","journal-title":"Eur J Intern Med"},{"issue":"1","key":"853_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s40200-019-00399-x","volume":"18","author":"M Davari","year":"2019","unstructured":"Davari M, Nabizadeh A, Kadivar M, Asl AA, Sarkheil P (2019) Healthcare resource utilization and cost of care for gaucher patients in Iran. J Diabetes Metab Disord 18(1):127\u2013132 PubMed PMID: 31275883. Pubmed Central PMCID: PMC6582176. Epub 2019\/07\/06. eng","journal-title":"J Diabetes Metab Disord"},{"key":"853_CR3","doi-asserted-by":"crossref","unstructured":"Stirnemann J, Belmatoug N, Camou F, Serratrice C, Froissart R, Caillaud C et al (2017) A review of gaucher disease Pathophysiology, clinical presentation and treatments. Int J Mol Sci. ;18(2). PubMed PMID: 28218669. Pubmed Central PMCID: PMC5343975. Epub 2017\/02\/22. eng.","DOI":"10.3390\/ijms18020441"},{"issue":"2","key":"853_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/17446651.2018.1445524","volume":"13","author":"SE Gary","year":"2018","unstructured":"Gary SE, Ryan E, Steward AM, Sidransky E (2018) Recent advances in the diagnosis and management of gaucher disease. Expert Rev Endocrinol Metab 13(2):107\u2013118 PubMed PMID: 30058864. Pubmed Central PMCID: PMC6129380. Epub 20180312. eng","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"2","key":"853_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1067\/S0022-3476(03)00302-0","volume":"143","author":"O Goker-Alpan","year":"2003","unstructured":"Goker-Alpan O, Schiffmann R, Park JK, Stubblefield BK, Tayebi N, Sidransky E (2003) Phenotypic continuum in neuronopathic gaucher disease: an intermediate phenotype between type 2 and type 3. J Pediatr 143(2):273\u2013276 PubMed PMID: 12970647. eng","journal-title":"J Pediatr"},{"issue":"1","key":"853_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.bcmd.2010.10.006","volume":"46","author":"B Rosenbloom","year":"2011","unstructured":"Rosenbloom B, Balwani M, Bronstein JM, Kolodny E, Sathe S, Gwosdow AR et al (2011) The incidence of parkinsonism in patients with type 1 gaucher disease: data from the ICGG gaucher registry. Blood Cells Mol Dis 46(1):95\u2013102 PubMed PMID: 21067946. Pubmed Central PMCID: PMC4662380. Epub 20101110. eng","journal-title":"Blood Cells Mol Dis"},{"issue":"1","key":"853_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jbspin.2016.12.002","volume":"85","author":"C Serratrice","year":"2018","unstructured":"Serratrice C, Bensalah N, Penaranda G, Bardin N, Belmatoug N, Masseau A et al (2018) Prevalence of autoantibodies in the course of gaucher disease type 1: A multicenter study comparing gaucher disease patients to healthy subjects. Joint Bone Spine 85(1):71\u201377 PubMed PMID: 28034821. Epub 20161226. eng","journal-title":"Joint Bone Spine"},{"key":"853_CR8","doi-asserted-by":"crossref","unstructured":"Riboldi GM, Di Fonzo AB, GBA (2019) Gaucher Disease, and Parkinson\u2019s Disease: From Genetic to Clinic to New Therapeutic Approaches. Cells. ;8(4). PubMed PMID: 31010158. Pubmed Central PMCID: PMC6523296. Epub 20190419. eng.","DOI":"10.3390\/cells8040364"},{"issue":"4","key":"853_CR9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ymgme.2021.06.009","volume":"133","author":"U Ramaswami","year":"2021","unstructured":"Ramaswami U, Mengel E, Berrah A, AlSayed M, Broomfield A, Donald A et al (2021) Throwing a spotlight on under-recognized manifestations of gaucher disease: pulmonary involvement, lymphadenopathy and gaucheroma. Mol Genet Metab 133(4):335\u2013344 PubMed PMID: 34229967. Epub 20210625. eng","journal-title":"Mol Genet Metab"},{"issue":"2","key":"853_CR10","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ymgme.2014.11.008","volume":"114","author":"K Weiss","year":"2015","unstructured":"Weiss K, Gonzalez A, Lopez G, Pedoeim L, Groden C, Sidransky E (2015) The clinical management of type 2 gaucher disease. Mol Genet Metab 114(2):110\u2013122 PubMed PMID: 25435509. Pubmed Central PMCID: PMC4312716. Epub 20141114. eng","journal-title":"Mol Genet Metab"},{"issue":"2","key":"853_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/(SICI)1098-1004(200002)15:2<181::AID-HUMU7>3.0.CO;2-S","volume":"15","author":"DL Stone","year":"2000","unstructured":"Stone DL, Tayebi N, Orvisky E, Stubblefield B, Madike V, Sidransky E (2000) Glucocerebrosidase gene mutations in patients with type 2 gaucher disease. Hum Mutat 15(2):181\u2013188 PubMed PMID: 10649495. eng","journal-title":"Hum Mutat"},{"key":"853_CR12","doi-asserted-by":"crossref","unstructured":"Mohindroo S (2009) Type-3 gaucher disease with bilateral necrosis of the neck of femur: a case report. Cases J. ;2:9380. PubMed PMID: 20072680. Pubmed Central PMCID: PMC2806396. Epub 20091222. eng.","DOI":"10.1186\/1757-1626-2-9380"},{"key":"853_CR13","unstructured":"Alaei MR, Tabrizi A, Jafari N, Mozafari H (2019 Winter) Gaucher disease: new expanded classification emphasizing neurological features. Iran J Child Neurol 13(1):7\u201324 PubMed PMID: 30598670. Pubmed Central PMCID: PMC6296697. eng"},{"issue":"5","key":"853_CR14","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.anpede.2023.10.001","volume":"99","author":"FA Palaz\u00f3n-Rico","year":"2023","unstructured":"Palaz\u00f3n-Rico FA, Lloreda-Garc\u00eda JM (2023) Ichthyosis as a manifestation of fetal gaucher. Anales De Pediatr\u00eda (English Edition) 99(5):360\u2013361","journal-title":"Anales De Pediatr\u00eda (English Edition)"},{"issue":"2","key":"853_CR15","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000324116","volume":"100","author":"S Haverkaemper","year":"2011","unstructured":"Haverkaemper S, Marquardt T, Hausser I, Timme K, Kuehn T, Hertzberg C et al (2011) Congenital ichthyosis in severe type II gaucher disease with a homozygous null mutation. Neonatology 100(2):194\u2013197 PubMed PMID: 21455010. Epub 2011\/04\/02. eng","journal-title":"Neonatology"},{"issue":"4","key":"853_CR16","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s12519-011-0309-1","volume":"7","author":"Z El-Morsy","year":"2011","unstructured":"El-Morsy Z, Khashaba MT, Soliman Oel S, Yahia S, El-Hady DA (2011) Glucosidase acid beta gene mutations in Egyptian children with gaucher disease and relation to disease phenotypes. World J Pediatrics: WJP 7(4):326\u2013330 PubMed PMID: 21633851. Epub 2011\/06\/03. eng","journal-title":"World J Pediatrics: WJP"},{"issue":"1","key":"853_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12881-019-0759-1","volume":"20","author":"J Sheth","year":"2019","unstructured":"Sheth J, Bhavsar R, Mistri M, Pancholi D, Bavdekar A, Dalal A et al (2019) Gaucher disease: single gene molecular characterization of one-hundred Indian patients reveals novel variants and the most prevalent mutation. BMC Med Genet 20(1):31 PubMed PMID: 30764785. Pubmed Central PMCID: PMC6376752. Epub 2019\/02\/16. eng","journal-title":"BMC Med Genet"},{"key":"853_CR18","doi-asserted-by":"crossref","unstructured":"Alasmar D (2015) Mar-Apr;35(2):127\u2009\u2013\u200932 Gaucher disease in Syrian children: common mutations identification, and clinical futures. Annals of Saudi medicine. PubMed PMID: 26336018. Pubmed Central PMCID: PMC6074127. Epub 2015\/09\/04. eng","DOI":"10.5144\/0256-4947.2015.127"},{"key":"853_CR19","unstructured":"Mozafari H, Taghikhani M, Rahimi Z, Vaisi-Raygani A, Ansari S, Khatami S et al Analysis of glucocerebrosidase gene mutations in Iranian patients with gaucher disease: identification of 6 novel mutations. Iran J Child Neurol. 2021 07\/01;15(3)."},{"issue":"1","key":"853_CR20","first-page":"40","volume":"12","author":"N Sardarpour","year":"2023","unstructured":"Sardarpour N, Bagherian H, Zafarghandi motlagh F, Shirzadeh T, Asnavandi S, Younesikhah S et al (2023) Mutational analysis and genotype investigation of less known gaucher mutations through haplotype analysis in Iranian gaucher patients. Int J Mol Cell Med 12(1):40\u201350 eng","journal-title":"Int J Mol Cell Med"},{"issue":"9","key":"853_CR21","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/sj.ejhg.5200845","volume":"10","author":"C Drugan","year":"2002","unstructured":"Drugan C, Procopciuc L, Jebeleanu G, Grigorescu-Sido P, Dussau J, Poenaru L et al (2002) Gaucher disease in Romanian patients: incidence of the most common mutations and phenotypic manifestations. Eur J Hum Genetics: EJHG 10(9):511\u2013515 PubMed PMID: 12173027. Epub 2002\/08\/13. eng","journal-title":"Eur J Hum Genetics: EJHG"},{"key":"853_CR22","doi-asserted-by":"crossref","unstructured":"Wan L, Hsu CM, Tsai CH, Lee CC, Hwu WL, Tsai FJ Mutation analysis of gaucher disease patients in taiwan: high prevalence of the RecNciI and L444P mutations. Blood cells, molecules & diseases. 2006 May-Jun ;36(3):422\u2013425. PubMed PMID: 16546416. Epub 2006\/03\/21. eng.","DOI":"10.1016\/j.bcmd.2006.02.001"},{"issue":"9","key":"853_CR23","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/jhg.2013.60","volume":"58","author":"R Tammachote","year":"2013","unstructured":"Tammachote R, Tongkobpetch S, Srichomthong C, Phipatthanananti K, Pungkanon S, Wattanasirichaigoon D et al (2013) A common and two novel GBA mutations in Thai patients with gaucher disease. J Hum Genet 58(9):594\u2013599 PubMed PMID: 23719189. Epub 2013\/05\/31. eng","journal-title":"J Hum Genet"},{"issue":"4","key":"853_CR24","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s12041-017-0821-8","volume":"96","author":"G G\u00f3mez","year":"2017","unstructured":"G\u00f3mez G, Arias S, C\u00e1rdenas L, Zoghbi D, Paradisi I (2017) GBA mutations in gaucher type I Venezuelan patients: ethnic origins and frequencies. J Genet 96(4):583\u2013589 PubMed PMID: 28947706. Epub 2017\/09\/28. eng","journal-title":"J Genet"},{"issue":"2","key":"853_CR25","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1177\/08830738050200020801","volume":"20","author":"A Perretti","year":"2005","unstructured":"Perretti A, Parenti G, Balbi P, Titomanlio L, Marcantonio L, Iapoce M et al (2005) Study of multimodal evoked potentials in patients with type 1 gaucher\u2019s disease. J Child Neurol 20(2):124\u2013128 PubMed PMID: 15794178. Epub 2005\/03\/30. eng","journal-title":"J Child Neurol"},{"issue":"8659","key":"853_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S0140-6736(89)90536-9","volume":"2","author":"A Zimran","year":"1989","unstructured":"Zimran A, Sorge J, Gross E, Kubitz M, West C, Beutler E (1989) Prediction of severity of gaucher\u2019s disease by identification of mutations at DNA level. Lancet (London England) 2(8659):349\u2013352 PubMed PMID: 2569551. Epub 1989\/08\/12. eng","journal-title":"Lancet (London England)"},{"issue":"7","key":"853_CR27","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1310\/hpj5107-553","volume":"51","author":"A Van Rossum","year":"2016","unstructured":"Van Rossum A, Holsopple M (2016) Enzyme replacement or substrate reduction? A review of gaucher disease treatment options. Hosp Pharm 51(7):553\u2013563 PubMed PMID: 27559188. Pubmed Central PMCID: PMC4981103. Epub 2016\/08\/26. eng","journal-title":"Hosp Pharm"}],"container-title":["Neurogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-025-00853-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10048-025-00853-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-025-00853-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T04:04:50Z","timestamp":1769400290000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10048-025-00853-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["853"],"URL":"https:\/\/doi.org\/10.1007\/s10048-025-00853-4","relation":{},"ISSN":["1364-6753"],"issn-type":[{"value":"1364-6753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent forms were signed by patients or legal representatives of patients. All methods were carried out in accordance with relevant guidelines and regulations. All experimental protocols were approved by ethical committee of Shahid Beheshti University of Medical Sciences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Informed consent forms were signed by guardians of patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}